John E. Ervin

1.6k citations
23 papers · 1.3k · 1 hit paper · h-index 16

Impact in

Papers in

    • Respiratory viral infections research 8
    • Influenza Virus Research Studies 3
    • Pneumonia and Respiratory Infections 2
    • SARS-CoV-2 and COVID-19 Research 4

John E. Ervin

23 papers receiving 1.2k citations

John E. Ervin's Hit Papers

Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults 2023 · 115 citations
1150+1+2Years since publication255075100

Peers

John E. Ervin
Comparison fields: 5 of 95
  • Infectious Diseases 371
  • Psychiatry and Mental health 208
  • Sensory Systems 52
  • Epidemiology 318
  • Rheumatology 112
Replace Yasuyo Kashiwagi with:
Yasuyo Kashiwagi Japan
Brahmchetna Bedi United States
Jacqueline M. Cliff United Kingdom
Ernie Riffer United States
Denise Morais da Fonseca Brazil
MICHAEL J. TARLOW United Kingdom
Kouji Takekuma Japan
Marcos Javier Ramos-Benítez United States
Joyce Y. Cheng United States
Sheila M. Nolan United States
John E. Ervin relative to Yasuyo Kashiwagi Japan Yasuyo Kashiwagi's profile →
Citations per field
00.5×5×10.4×
Yasuyo Kashiwagi · 1×
Citations per year

Countries citing papers authored by John E. Ervin

Since Specialization
Citations

This map shows the geographic impact of John E. Ervin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Ervin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Ervin more than expected).

Fields of papers citing papers by John E. Ervin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Ervin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Ervin. The network helps show where John E. Ervin may publish in the future.

Co-authors

The 25 scholars most cited alongside John E. Ervin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John E. Ervin Line = papers co-authored together John E. Ervin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2020226
2 2018213
3 2013137
4
Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults
Hit paper breakdown →
2023115
5 201999
6 201493
7 201970
8 202246
9 201441
10 201732
11 201132
12 201527
13 202326
14 202224
15 202319
16 202418
17 201316
18 202112
19 20247
20 20225

About John E. Ervin

John E. Ervin is a scholar working on Epidemiology, Infectious Diseases, Immunology, Rheumatology and Endocrinology, having authored 23 papers that have together received 1.3k indexed citations. Recurring topics across this work include Respiratory viral infections research (8 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Osteoarthritis Treatment and Mechanisms (3 papers), Influenza Virus Research Studies (3 papers), Pneumonia and Respiratory Infections (2 papers), vaccines and immunoinformatics approaches (1 paper) and Tracheal and airway disorders (1 paper). The work is most often cited by research in Infectious Diseases (371 citations), Psychiatry and Mental health (208 citations), Sensory Systems (52 citations), Epidemiology (318 citations) and Rheumatology (112 citations). John E. Ervin has collaborated with scholars based in United States, Belgium and Netherlands. Frequent co-authors include Alan Kivitz, Scott J. Mellis, Haobo Ren, Paul J. Tiseo, Robin Burges, Peter D. Hanson, James N. Campbell, Randall M. Stevens, Peter F. Wright and Glenn Y. Ishioka. Their work appears in journals such as Open Forum Infectious Diseases, The Lancet Infectious Diseases, The Journal of Infectious Diseases, Arthritis & Rheumatology and Human Vaccines & Immunotherapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact